Dudediligence.

MapLight Therapeutics, Inc

MPLTNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$56.9M

38 notices · 2,650,054 sh

Oct 2025 to Oct 2026

Reported ·

$17.5M

93 sales · 6 buys · $109.4M bought

Oct 2025 to Jun 2026

The two figures cover different periods.

63 of 93 reported sales carry the 10b5-1 box. Together they are 1.52% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-16: Hanson Kristopher, Form 1442026-08-03: Lillie James Woodruff, Form 1442026-07-30: Novo Holdings A/S, Form 1442026-07-17: ANATOL KREITZER, Form 1442026-07-17: JONATHAN GILLIS, Form 1442026-07-15: Foff Erin Pennock, Form 1442026-07-15: Kroeger Christopher A., Form 1442026-07-15: Hanson Kristopher, Form 1442026-07-15: Lillie James Woodruff, Form 1442026-07-15: ROBERT MALENKA, Form 1442026-07-15: Anatol Kreitzer, Form 1442026-07-15: Jonathan Gillis, Form 1442026-05-04: Kroeger Christopher A., Form 1442026-05-04: Setia Vishwas, Form 1442026-05-04: Foff Erin Pennock, Form 1442026-05-04: Lillie James Woodruff, Form 1442026-05-04: Hanson Kristopher, Form 1442026-04-27: ANATOL KREITZER, Form 1442026-04-27: JONATHAN GILLIS, Form 1442026-04-15: Foff Erin Pennock, Form 1442026-04-15: Lillie James Woodruff, Form 1442026-04-15: Setia Vishwas, Form 1442026-04-15: Hanson Kristopher, Form 1442026-04-15: Kroeger Christopher A., Form 1442026-04-15: ROBERT MALENKA, Form 1442026-04-15: Anatol Kreitzer, Form 1442026-04-15: Jonathan Gillis, Form 1442026-02-24: ROBERT MALENKA, Form 1442026-02-23: ROBERT MALENKA, Form 1442026-02-20: ROBERT MALENKA, Form 1442026-02-13: ROBERT MALENKA, Form 1442026-02-11: ROBERT MALENKA, Form 1442026-02-10: ROBERT MALENKA, Form 1442026-02-03: ROBERT MALENKA, Form 1442026-02-02: ROBERT MALENKA, Form 1442026-01-30: ROBERT MALENKA, Form 1442026-01-29: ROBERT MALENKA, Form 1442026-01-28: ROBERT MALENKA, Form 1442025-10-28: Novo Holdings A/S, bought2025-10-28: Catalyst4, Inc., bought2026-01-28: Malenka Robert C., sold2026-02-02: Malenka Robert C., sold2026-02-10: Garnett Timothy John, bought2026-02-10: Malenka Robert C., sold2026-02-13: Malenka Robert C., sold2026-02-18: Pavlov George, bought2026-02-20: Malenka Robert C., sold2026-04-15: Kroeger Christopher A., sold2026-04-15: GILLIS JONATHAN, sold2026-04-15: Lillie James Woodruff, sold2026-04-15: Hanson Kristopher, sold2026-04-15: Malenka Robert C., sold2026-04-15: Foff Erin Pennock, sold2026-04-15: Kreitzer Anatol, sold2026-04-15: Setia Vishwas, sold2026-04-27: GILLIS JONATHAN, sold2026-04-27: Kreitzer Anatol, sold2026-05-04: Kroeger Christopher A., sold2026-05-04: Lillie James Woodruff, sold2026-05-04: Hanson Kristopher, sold2026-05-04: Foff Erin Pennock, sold2026-05-04: Setia Vishwas, sold2026-05-07: Kroeger Christopher A., sold2026-05-07: Lillie James Woodruff, sold2026-05-07: Foff Erin Pennock, sold2026-05-11: Hanson Kristopher, sold2026-05-18: Kroeger Christopher A., sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-16Hanson Kristopher, General Counsel$199,429
16,509 shplan 2025-12-29Form 4s on file end Jun 23144 ↗
2026-08-03Lillie James Woodruff, Chief Scientific Officer$287,508
22,082 shplan 2025-12-29Form 4s on file end Jun 23144 ↗
2026-07-30Novo Holdings A/S, Former Affiliate$24.0M
1,600,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-17ANATOL KREITZER, Chief Discovery Officer$639,179
17,173 shplan 2025-12-24Form 4s on file end Jun 23144 ↗
2026-07-17JONATHAN GILLIS, CAAO and PAO$687,416
18,469 shplan 2025-12-26Form 4s on file end Jun 23144 ↗
2026-07-15Foff Erin Pennock, Chief Medical Officer$1,825,670
48,158 shplan 2025-12-29Form 4s on file end Jun 23144 ↗
2026-07-15Kroeger Christopher A., Chief Executive Officer$5,771,039
152,230 shplan 2025-12-29Form 4s on file end Jun 23144 ↗
2026-07-15Hanson Kristopher, General Counsel$625,818
16,508 shplan 2025-12-29Form 4s on file end Jun 23144 ↗
2026-07-15Lillie James Woodruff, Chief Scientific Officer$714,035
18,835 shplan 2025-12-29Form 4s on file end Jun 23144 ↗
2026-07-15ROBERT MALENKA, Director$664,828
17,537 shplan 2025-12-26Form 4s on file end Jun 23144 ↗
2026-07-15Anatol Kreitzer, Chief Discovery Officer$1,375,526
36,284 shplan 2025-12-24Form 4s on file end Jun 23144 ↗
2026-07-15Jonathan Gillis, CAAO and PAO$1,401,874
36,979 shplan 2025-12-26Form 4s on file end Jun 23144 ↗
2026-05-04Kroeger Christopher A., Chief Executive Officer$7,259,629
236,470 shplan 2025-12-29144 ↗
Form 4, 2026-05-06: sold 49,744 at $28.39 Form 4 ↗
2026-05-04Setia Vishwas, Chief Financial Officer$1,116,590
36,371 shplan 2025-12-29144 ↗
Form 4, 2026-05-06: sold 36,371 at $28.17 Form 4 ↗
2026-05-04Foff Erin Pennock, Chief Medical Officer$1,679,843
54,718 shplan 2025-12-29144 ↗
Form 4, 2026-05-06: sold 50,280 at $28.39 Form 4 ↗
2026-05-04Lillie James Woodruff, Chief Scientific Officer$1,609,540
52,428 shplan 2025-12-29144 ↗
Form 4, 2026-05-06: sold 51,707 at $28.40 Form 4 ↗
2026-05-04Hanson Kristopher, General Counsel$854,504
27,834 shplan 2025-12-29144 ↗
Form 4, 2026-05-06: sold 13,917 at $27.89 Form 4 ↗
2026-04-27ANATOL KREITZER, Chief Discovery Officer$1,351,759
45,422 shplan 2025-12-24144 ↗
Form 4, 2026-04-29: sold 45,422 at $29.66 Form 4 ↗
2026-04-27JONATHAN GILLIS, CAAO and PAO$2,078,290
69,835 shplan 2025-12-26144 ↗
Form 4, 2026-04-29: sold 69,835 at $29.89 Form 4 ↗
2026-04-15Foff Erin Pennock, Chief Medical Officer$93,813
3,472 shplan 2025-12-29144 ↗
Form 4, 2026-04-17: sold 3,213 at $27.03 Form 4 ↗
2026-04-15Lillie James Woodruff, Chief Scientific Officer$132,290
4,896 shplan 2025-12-29144 ↗
Form 4, 2026-04-17: sold 4,513 at $27.16 Form 4 ↗
2026-04-15Setia Vishwas, Chief Financial Officer$80,799
2,990 shplan 2025-12-29144 ↗
Form 4, 2026-04-17: sold 2,922 at $26.89 Form 4 ↗
2026-04-15Hanson Kristopher, General Counsel$49,366
1,827 shplan 2025-12-29144 ↗
Form 4, 2026-04-17: sold 1,827 at $26.89 Form 4 ↗
2026-04-15Kroeger Christopher A., Chief Executive Officer$562,610
20,822 shplan 2025-12-29144 ↗
Form 4, 2026-04-17: sold 19,187 at $27.16 Form 4 ↗
2026-04-15ROBERT MALENKA, Director$232,183
8,593 shplan 2025-12-26144 ↗
Form 4, 2026-04-17: sold 8,593 at $26.90 Form 4 ↗
2026-04-15Anatol Kreitzer, Chief Discovery Officer$135,100
5,000 shplan 2025-12-24144 ↗
Form 4, 2026-04-17: sold 3,316 at $26.61 Form 4 ↗
2026-04-15Jonathan Gillis, CAAO and PAO$108,080
4,000 shplan 2025-12-26144 ↗
Form 4, 2026-04-17: sold 3,590 at $26.61 Form 4 ↗
2026-02-24ROBERT MALENKA, Director$13,355
736 shplan 2025-12-26no Form 4 on file144 ↗
2026-02-23ROBERT MALENKA, Director$207,491
11,264 shplan 2025-12-26no Form 4 on file144 ↗
2026-02-20ROBERT MALENKA, Director$39,577
2,195 shplan 2025-12-26144 ↗
Form 4, 2026-02-24: sold 14,195 at $18.34 Form 4 ↗
2026-02-13ROBERT MALENKA, Director$220,686
12,116 shplan 2025-12-26144 ↗
Form 4, 2026-02-18: sold 12,116 at $18.21 Form 4 ↗
2026-02-11ROBERT MALENKA, Director$4,338
241 shplan 2025-12-26no Form 4 on file144 ↗
2026-02-10ROBERT MALENKA, Director$119,963
6,622 shplan 2025-12-26144 ↗
Form 4, 2026-02-12: sold 6,863 at $18.12 Form 4 ↗
2026-02-03ROBERT MALENKA, Director$18
1 shplan 2025-12-26no Form 4 on file144 ↗
2026-02-02ROBERT MALENKA, Director$126,835
7,039 shplan 2025-12-26144 ↗
Form 4, 2026-02-04: sold 7,040 at $18.02 Form 4 ↗
2026-01-30ROBERT MALENKA, Director$119,737
6,612 shplan 2025-12-26no Form 4 on file144 ↗
2026-01-29ROBERT MALENKA, Director$394,470
21,262 shplan 2025-12-26no Form 4 on file144 ↗
2026-01-28ROBERT MALENKA, Director$121,690
6,524 shplan 2025-12-26144 ↗
Form 4, 2026-01-30: sold 34,398 at $18.49 Form 4 ↗